Alkermes ALKS
NASDAQ ALKS
$40.80 +0.65 (+1.62%)
At close: Sep 29, 2026 · 4:00 PM EDT

Alkermes (ALKS) Other financing activities (2011 - 2026)

Updated

Alkermes (ALKS) posted Other financing activities of $1.1 million for Q2 2026, down 34.7% from $1.68 million a year earlier and down 95.3% from the prior quarter.

Analysis

Alkermes (ALKS) Other financing activities (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Other financing activities at Alkermes was $25.11 million, down 19.2% year-over-year; for FY2025, it came in at $31.03 million, up 4.7% from FY2024.

  • Annual Other financing activities has increased for five consecutive years, with a five-year compound annual growth rate of 32.1% (FY2020 to FY2025).
  • In prior years, Alkermes' Other financing activities was $29.64 million in FY2024 (+4.1%), $28.47 million in FY2023 (+56.4%), $18.2 million in FY2022 (+9.9%) and $16.57 million in FY2021 (+115.2%).
  • Quarterly Other financing activities has run from a low of $266,000 in Q4 2025 to a high of $28.78 million in Q1 2025 over five years.
  • On a year-over-year basis, Other financing activities has declined in each of the last three quarters, with an average decline of 7.6% over the last eight quarters.
  • The strongest year-over-year quarter for Other financing activities in the past five years was Q4 2023, with growth of 695.3%; the weakest was Q4 2022, with a decline of 89.8%.
  • According to Business Quant data, Other financing activities for the three prior quarters was $23.44 million (Q1 2026), $266,000 (Q4 2025) and $307,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Alkermes 6.73 Bn 3.86 Bn 397.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Mn
Mar 31, 2026 23.44 Mn
Dec 31, 2025 266,000.00
Sep 30, 2025 307,000.00
Jun 30, 2025 1.68 Mn
Mar 31, 2025 28.78 Mn
Dec 31, 2024 344,000.00
Sep 30, 2024 293,000.00
Jun 30, 2024 651,000.00
Mar 31, 2024 28.35 Mn
Dec 31, 2023 2.39 Mn
Sep 30, 2023 796,000.00
Jun 30, 2023 540,000.00
Mar 31, 2023 24.74 Mn
Dec 31, 2022 301,000.00
Sep 30, 2022 320,000.00
Jun 30, 2022 514,000.00
Mar 31, 2022 17.07 Mn
Dec 31, 2021 2.94 Mn
Sep 30, 2021 2.51 Mn
API Access

Alkermes Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ALKS&period=max&api_key=YOUR_API_KEY